Second-line myelofibrosis treatment – the potential of JAK2 inhibitor NS-018
Can venetoclax be used to treat multiple myeloma (MM)?
The use of CLL-IPI, a new prognostic index for CLL
Encouraging data from the RAY trial 3-year follow-up
New nivolumab combination therapies for AML